Clinical Trial Update: Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing brodalumab with guselkumab in plaque psoriasis patients with inadequate response to ustekinumab was terminated, and results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Guselkumab (guselkumab)
• brodalumab (brodalumab)

Snippet

Sponsor: LEO Pharma | Conditions: Plaque Psoriasis, Psoriasis Vulgaris | Phase 4 | Status: TERMINATED | Results posted: 2024-01-09